People
With a massive $200 million Series A financing round, EQRx launches with the mission of creating novel medicines that are more affordable for patients and more sustainable for healthcare systems.
As is often the case at the beginning and end of the year, a number of companies announced layoffs. Other news is related to lawsuits and an overall positive story about cancer death rates. Here’s a look.
Turbine, a simulation-first drug discovery company, announced the formation of its Scientific Advisory Board with the appointments of Dr. Annalisa Jenkins, Dr. Mihriban Tuna, and Dr. Alan Barge.
Wellington Partners, a leading European venture capital firm investing in early- and growth-stage life science companies, announced that Dr. Karl Naegler joined Wellington as a Managing Partner on January 1, 2020.
Synthetic biology – an engineering approach to biological science– is gaining traction in biotechnology worldwide.
A Chinese scientist living abroad who has been accused of accepting stolen intellectual property to benefit a pharma startup in China has been extradited to the United States.
Biocon Ltd,, an innovation-led global biopharmaceuticals company, announced that it has appointed Mr. M.B. Chinappa as Chief Financial Officer of its subsidiary Biocon Biologics India Ltd.
BioSpace spoke to leaders from various corners of the industry who provided their insights into what the coming year is likely to hold for their particular sphere.
Pharma, biotech and life sciences companies boost their leadership ranks with this weeks Movers & Shakers.
“We are Earth’s Tech Support,” declared Randall Kirk, Executive Chairman of the Board of Directors and former CEO of Intrexon. His company is one of the biggest developers of synthetic biology (or engineering biology) applications in therapeutics, agriculture and chemicals.
PRESS RELEASES